News & Media
Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform
Paris, June 2025 Partex has reduced the end-to-end timeline for antibody optimization from > 700 hours to 48 hours – a reduction by 93%. This enables faster, ...
Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658
Partnership builds on the successful launch of AK0707 collaboration, advancing next-generation oncology asset through AI-driven life cycle management Frankfur...
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
Frankfurt, Germany & Miami, FL, USA – March 17, 2025 – Partex NV and Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical compan...
Partex Announces Strategic Collaboration with Princeton Drug Discovery Ltd for Out-Licensing of PDD-87
Frankfurt, Germany, 20th February, 2025 – Partex is pleased to announce a strategic collaboration with Princeton Drug Discovery Ltd (PDD), a leading biotech c...
Pimpri Chinchwad University Hosts Faculty Development Program on AI and Generative AI to Strengthen Academic-Industry Synergy
Pune, [13-02-2025]: Pimpri Chinchwad University (PCU) reaffirmed its commitment to technological excellence and academic innovation by organizing a two -day Fac...
Die Arbeitsgemeinschaft Internistische Onkologie (AIO) und AMRIT entwickeln innovativen onkologischen Datenhub
Pressemitteilung vom 08.01.2025 Die Amrit AG, ein Unternehmen der Partex Gruppe - einem führenden Anbieter von KI-Lösungen im Gesundheitswesen - gibt heute de...
Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707
Partnership aims to expand therapeutic potential of proprietary autotaxin inhibitor through AI-driven approach Frankfurt, Germany – Date – Partex, a leader in ...
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development
Frankfurt, Germany, 3 rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce i...
Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce its partnership wi...
Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established ...
Innovative AI technology in oncology: Partex Group presents results from a pilot project
During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the results of a pilot project carr...
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing
Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical giant Sanofi, ...
Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative
January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health data analysis, and AIO Studien gGmbH, ...
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV ...
AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary medical exchange,...
OncoCoin AG donates for a charity bicycle tour: Tour of Hope
Bad Hersfeld / Germany, Aug 02, 2022 – Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took place a few days ago in the Bad Hersfeld St...
Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Le...
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, G...
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBOR...
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN...
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf g...
Der Pharma-Visionär
Mit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere...
Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona
Hessen fördert Forschungsprojekt mit rund 1,4 Mio. Euro. Mit einem Zuschuss von 1,4 Mio. Euro unterstützt Hessen die Entwicklung eines Wirkstoffkandidate...
New app for cancer patients
Das Eschborner Unternehmen PartexAI hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunte...
Role of AI soars in tackling Covid-19 pandemic
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging from diagnosing risk to doubt-clearing, from...
PartexAI Announces Major Findings in Potential Combination Therapies for COVID-19
Disclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended to be a subs...
PartexAI wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — PartexAI AG has been honored with the Silver Edison Award 2020 for its proprietary Ontosight Ⓡ Explore platform. The ...
PartexAI: Big Steps to Combat the Coronavirus
ESCHBORN, Germany, March 18, 2020 /PRNewswire/ — The German company PartexAI AG, also known as the “Google of the healthcare industry” ( Welt ) – is takin...
PartexAI Opens Its Ontosight® AI Search Platform to COVID-19 Research
FRANKFURT, Germany, March 15, 2020,/PRNewswire/ — PartexAI AG has made its proprietary Ontosight ® AI search platform available to medical researchers aro...
PartexAI AG announces the appointment of Christian Bigatà Joseph as Chief Financial Officer (CFO) and Dr. Katharina Schreeb as Chief Medical Officer (CMO)
Eschborn, 11.03.2020 – The Supervisory Board of PartexAI AG has appointed Christian Bigatà Joseph (45) as CFO, effective as of February 1, 2020. Christian...
PartexAI Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification
Pune, India, February 13, 2020 – PartexAI Consulting Services Private Limited, a subsidiary of PartexAI AG, is delighted to have been awarded ISO/IEC 27001:2013...
Catana Capital: New collaboration with Life Science AI pioneer PartexAI
Catana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As a pioneer in...
PartexAI and Wiley partner to provide AI-powered solutions over comprehensive research literature
Frankfurt, Germany, October 15, 2019 – PartexAI AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE: JW-B) to enable PartexAI’s propr...
PartexAI and ChemAxon partner to get more out of life science data
Frankfurt, Germany – Budapest, Hungary, September 16, 2019 – PartexAI announces an official partnership with ChemAxon, getting the most value out from life scie...
PartexAI Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President
Hoboken, New Jersey, September 16, 2019- PartexAI Inc., a subsidiary of PartexAI AG, announced today the appointment of Stratos Davlos as Chief Technology Offic...
Traum aller Anleger
PartexAI aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt den Aktio...
PartexAI Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA
Hoboken, New Jersey, September 12, 2019 – PartexAI Inc, a subsidiary of PartexAI AG, Frankfurt, which has developed the most comprehensive, industry validate...
PartexAI and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer
Hoboken, NJ, August 5, 2019 – PartexAI Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the...
AI CTP engine estimated failure for Biogen’s aducanumab
While drug development can be incredibly lucrative, it is a very risky business. German company PartexAI has developed a domain-specific AI prediction engine, w...
Predicting Drug Flops with AI
While drug development can be incredibly lucrative, it is a very risky business. German company PartexAI has developed a domain-specific AI prediction engine, w...
Google for Healthcare
Gunjan Bhardwaj chose Germany as the place to launch his advanced search and discovery solution. His company assists the healthcare industry by organizing and ...
Lessons Learned from Other Industries
While the auto industry is embracing big data and its opportunities for new services and deep insights, auto companies are wary of security risks that could spa...
PartexAI Launches Worldwide Academic Access Program for its Flagship Ontosight.ai
Frankfurt, Germany, May 21, 2019 -- PartexAI announced today the launch of Ontosight Academic, a platform that provides academic researchers free access to a va...
PartexAI AG wird Mitglied im Bundesverband für Künstliche Intelligenz (KI)
Der am 16.3.2018 in München gegründete KI-Bundesverband verfolgt das Ziel, Deutschland als attraktiven Wirtschaftsstandort für die Weiterentwicklung von KI zu e...
Künstliche Intelligenz auf dem Vormarsch
Veröffentlicht am 18.06.18 um 17:32 Uhr Quelle: © hessenschau Der regionale Fernsehsender Hessenschau berichtet im Rahmen der in Frankfurt am Main stat...
Big Pharma setzt auf Big Data gegen die Forschungsflaute
Die Digitalisierung wird zum Hoffnungsträger: Neue Analysen, Vernetzung sowie größere Datenmengen könnten der Arzneimittelentwicklung Schub geben. Frank...
Google für die Pharmabranche
Inder und Schwabe Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland PartexAI aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, ...
Wir wollen Daten demokratisieren
Dr. Gunjan Bhardwaj ist Gründer und CEO der PartexAI AG. Mit Hilfe von Künstlicher Intelligenz, Blockchain und Big-Data-Analyse-Anwendungen hat ihre Software iP...
Ein Gründer bekämpft Krebs mit künstlicher Intelligenz
Gunjan Bhardwaj hilft Pharmakonzernen, mehr über Krankheiten herauszufinden. Durch künstliche Intelligenz sollen sie schneller Medikamente entwickeln. Fr...
„Deutsche Tugenden sind bei KI und Deep-Tech ein Wettbewerbsvorteil“
Christian Angermayer, Apeiron Investment Group, über die internationale KI-Szene, die Möglichkeiten, die sie eröffnet, und warum Deutschland das Potenzial hat, ...
Pioniere der nächsten digitalen Revolution
Ob Medizin, Bankgeschäfte oder Mobilität: In Zukunft soll Künstliche Intelligenz aus dem Alltag nicht mehr wegzudenken sein. Hessische Unternehmer und Forscher ...
PartexAI WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES
Eschborn, Januar 2019. Das weltweit angesehene US-Analystenhaus Gartner Inc. veröffentlicht jährlich seinen Hype Cycle für Life Sciences, um Unternehmensvorstän...
Google für die Gesundheitsbranche
Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland PartexAI aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen aus dem I...
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years to be approved. High costs, 90% failu...
PartexAI, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
Frankfurt, Germany – PartexAI AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain ...
PartexAI’ Clinical Trial Prediction Engine predicted Aducanumab Failure
Frankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to the tune of $18Bn for investors aft...
An AI Firm Wants to Predicts Costly Pharma Flops
Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales of about $3.7 bil...
Finger on the Pulse: GTC Spotlights Startups Propelling AI in Healthcare
It can be hard to stay healthy in a convention center filled with thousands of people — unless, of course, you’re at the GPU Technology Conference, where health...
Pharma & Healthcare Analytics Is Going To Be The Next Big Thing In India
The Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by the Federation of Indian...
PartexAI: Real-Time Data Analytics to Empower Decision Making
The evolution of artificial intelligence (AI) has taken the healthcare sector by a storm promising enhanced data analytics for effective decision making. Howeve...
8 Startups Ahead of the Pulse in Healthcare
AI enabled healthcare is swiftly becoming today’s reality, fueled by innovative startups in the field. These startups are leveraging GPUs to develop AI applicat...
Big Pharma relies on Big Data to combat the research slump
Digitalization is becoming a source of hope: new analyses, networking, and larger amounts of data could give a boost to drug development. "Data, data eve...
Pharma Outlook: 12 Trends to Watch in 2019
What does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the...
Mobilize data trapped in silos with Blockchain and AI
 The original video was published on Talk Business 360.
Can AI help in Drug Development ?
This is the talk given by PartexAI Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 - an event by Analytics Vidhya. Lot of analytics companies ...
The Story Of Disrupting AI-Driven Team
Discover the story of bringing together two worlds- AI and healthcare. Gunjan Bhardwaj, Founder and CEO of PartexAI, guides us through an inspiring journey of d...
Building AI Foundation
How to build the foundations of AI your team needs?- A deep dive. Gaurav Tripathi, Co-Founder and CTO of PartexAI, shares his experience as a data scientist and...
PartexAI INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES
Eschborn, January 2019. The world-renowned US analyst firm Gartner Inc. annually publishes its Hype Cycle for Life Sciences to help C-Level understand innovativ...
How blockchain and AI can help us decipher medicine's big data
When diagnosed with a disease, it's often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they...
The art of possibility: The talks of TED@Merck KGaA, Darmstadt, Germany
The possibilities life affords us are endless. We can find them everywhere, at the micro and macro levels and across all fields. Do you see them? Look closer: t...
AI able to ‘predict impact of minor changes’ to manufacturing
Industry 4.0 has been pitched as able to transform the way pharma manufacturing operates, Lawrence Ganti, of PartexAI, explains how AI can be used to improve ef...
Blockchain in Healthcare: 6 Possible Use Cases
According to one study, the United States healthcare system ranked last among 11 industrialized nations in terms of access, equity, quality, efficiency, and hea...
5 predictions for AI in 2019
While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can the industry expect next ye...
Five AI Healthcare Startups Bringing Us Closer to Cures
Clinical Informatics tells us that: “Every year in the U.S., approximately 2 million patients participate in roughly 3000 clinical trials; six million patients ...
PartexAI Brings Blockchain to Pharma
Global AI firm PartexAI launched an innovative blockchain platform to dramatically raise the amount of data available for drug research and discovery. This new ...
Founder fights cancer with artificial intelligence
Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to deve...
AI-based drug development to broaden gap between pharmaceuticals
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a new medicine, experts said. ...
Google for Pharma
Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched PartexAI, a sophisticated ecosystem of continuous analytic...
We want to democratize data
Dr. Gunjan Bhardwaj is the founder and CEO of PartexAI AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus ...
How artificial intelligence impacts preventative care
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking to artificial intelligence (AI)...
More transparency would bolster big pharma’s image
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list. The public cites hig...
PartexAI is working on solutions in response to GDPR and other data privacy restrictions
PartexAI is at the forefront of decision-making technology as the company works in data aggregation to provide to researchers, pharmaceutical companies, ...
Why AI and blockchain are the solutions to developing orphan drug
We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at sma...
Who will be the disruptor that pharma is waiting for?
Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to a smaller company with fe...
Blockchain can take pharma collaboration and innovation to new heights
The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Compani...
New Blockchain Platform from PartexAI Will Bring Us Better, Cheaper Drugs
Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj came to...
How Eliminating Data Silos Will Democratize Pharma R&D
In this special guest feature, Gunjan Bhardwaj, Founder and CEO of PartexAI , discusses how data silos in pharma prevent the latest advancements in machine lea...
Why blockchain is a dream come true for pharma researchers
Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are often thrilled about laboratory exp...
Four steps to building an innovation culture in pharma
The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the b...
How AI and Blockchain Can Help Pharma Companies Avoid Duplicative Work
“If I have seen further than others, it is by standing upon the shoulders of giants.” – Isaac Newton There is nothing new under the sun. Innovation is a...
![How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation](/technologies/assets/Image-8.svg)
How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation
Ask the average person about the blockchain, and you’d be lucky if one in ten could tell you – even in vague terms – how the technology works, or even what it i...
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success
Gunjan Bhardwaj is the Founder and CEO of the PartexAI group. He was earlier with the Boston Consulting Group and before that the leader of the global business ...
PartexAI launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be available to those who could formulate a ...
3 Reasons why PartexAI is bringing Blockchain to Pharma
Don’t let the hype around blockchain fool you. Blockchain is only as useful as the solutions it provides. With all the excitement around blockchain as a ...
PartexAI launches Blockchain platform to drive Pharma innovation
Researchers can now share unpublished data securely on the blockchain Global AI company PartexAI launched today a groundbreaking blockchain platform to...
Beyond competition, PartexAI believes in collaboration to nurture the ecosystem in a data-driven world
In the last five years, data science has continued to make rapid advances, particularly in the fields of machine learning and deep learning. Organisations now h...
Gunjan Bhardwaj on “The American Dream”
Hosted by radio and TV personality Craig Sewing, ‘The American Dream’ is a national cable talk show that goes against the grain of all the negative stuff you ke...
When should pharma execs actually care about AI?
Artificial intelligence (AI) has recently garnered a lot of attention, and it is transforming the way pharma execs use their data. tech emergency, an AI market ...
Consumer perceptions of pharma
Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring bad reputation. It’s n...
How Blockchain And AI Can Help Pharma Focus On Innovation Rather Than Advertising
Pharmaceutical companies spend a tremendous amount of money each year on advertising and marketing. According to the Pew Charitable Trusts, "In 2012, the pharma...
How blockchain will revolutionize clinical trials
The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To justify the costs of drug developm...
Big data, AI and social media are the changing face of pharma marketing
Pharma should lean more on the power of big data and AI to identify and target individuals who possess the greatest social capital and influence relevant to a g...
How AI And Blockchain Can Revolutionize Pharmaceutical Trials
It’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval, resulting in enormous drug development e...
To unlock innovation, pharma needs to be honest about failure
Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation – and it’s a lesson the pharmaceutical indust...
How AI and blockchain can reduce corruption in Big Pharma
Gunjan Bhardwaj gives his opinion on how new technologies can help solve some of the problems in the pharma industry. The pharmaceutical industry today f...
AI and Blockchain Platform Set to Revolutionize Drug Discovery
With the burgeoning advancement and adoption of advanced technologies such as artificial intelligence in various fields, there’s hope for a better future. These...
Blockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery
PartexAI AG announced a revolutionary update is coming soon to their iPlexus platform that will harness the power of blockchain technology and artificial intell...
German Blockchain, AI Platform to ‘Democratize’ Drug Development
Germany-based company PartexAI AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies in early-stag...
PartexAI has been accepted to NVIDIA Inception Program
PartexAI will now be a part of NVIDIA Inception Program. A program that is designed to nurture dedicated and exceptional startups who are revolutionizing indust...
Is Open Data the Silver Bullet for Better Drugs?
Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply ...
New Blockchain and AI-based Platform to Revolutionize Drug Discovery
PartexAI aims to democratize drug development with launch of new iPlexus Eschborn, Germany: PartexAI AG announced today a groundbreaking update comin...
How Blockchain leverages the Power of Failure in Drug Development for the benefit of the patient
2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a challenging question. That is where Artificial...
PartexAI's New North American Affiliate is Bringing AI Innovation to the US Pharma Industry
It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to corruption charges, the issues that American...
PartexAI Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies
Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: PartexAI, a leader in artificial intelligence and data...
PartexAI supports the European Summer School in Logic, Language and Information
In late 90s, internet solved the problem of data access. Then came the explosion of data with the web search and social media. Necessity to find relevant data &...
PartexAI Announces New North American Affiliate Helmed by Former Merck KGaA Executive
Leader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ -- PartexAI , a leader...
Innoplexus supports the WHO “Save Lives – Clean Your Hands” -Campaign 2018 with AI technology
Eschborn, 5th May 2018 – PartexAI AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by measuring the effect of its online and...
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of PartexAI AG. In December 2017, Amazon, JPMorgan Chase ...
Five use cases for blockchain in pharma Pharmaphorum
As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockch...
TiE Inflect 2018 PartexAI AG as a 2018 TiE50 Finalist
April 23, 2018 – Eschborn – PartexAI AG is excited to announce that it has been selected as a "2018 TiE50 Finalist" for the prestigious TiE50 Awards Progra...
Third Wave of Artificial intelligence promises the first AI Summit organised by PartexAI and Frankfurt School of Finance & Management
Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by PartexAI and Frankfurt School of Finance & Management...
Drug Prices Are Too Expensive: Here's How Technology Can Fix That Forbes Technology Council
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of PartexAI AG. The cost of drug development has skyrocke...
Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum
Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply cha...
How PartexAI uses smart and on-edge technology to help its pharma clients find relevant answers hidden in unstructured data
When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to differentiate their early stage assets...
Leveraging AI and Blockchain to Transform Healthcare
Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging ...
How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum
The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines o...
Why pharma companies need to upgrade their intelligence Pharmaphorum
In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive...
How artificial intelligence powers healthcare innovation Digital Commerce 360
When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel therapeutics to market. ...
Solving the Big Data problem in pharma innovation Pharmaphorum
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry . What can be done to overcome th...
Using AI & Machine Learning, Indo-German company PartexAI is helping reduce the time it takes for medicines to reach patients
Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can be repurposed and used ...
How AI, blockchain, and big data can reduce drug development costs Pharmaphorum
Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. ...
How AI Is Transforming The Future Of Healthcare
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of PartexAI AG. I recently wrote about five technologies ...
PartexAI strengthens its global leadership team with accomplished leaders- appoints Silke Otte as Chief Marketing Officer and Graeme Mcfarlane as the Chief Commercial Officer
PartexAI AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as...
Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins PartexAI as CEO, Americas
PartexAI AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as...
PartexAI @ Machine Intelligence Summit, Berlin 2017
PartexAI AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th Jul...
Accelerating innovation in Pharma with Artificial Intelligence & Big Data
As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for...
PartexAI Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017
PartexAI unveiled iPlexus at Bio-IT, 2017, Boston . iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) ...
PartexAI featured on Inc.
3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information i...
PartexAI talks about Cybersecurity with Entrepreneur.com
PartexAI talks about Cybersecurity with Entrepreneur.com Are Indian Tech Start-ups Robust Enough To Run Fast With Nation's Digital Drive? The Zom...
PartexAI at Bio-IT World
Excited to announce that PartexAI is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at ...
PartexAI Featured in DataQuest
PartexAI launches iPlexus to transform decision support in the Life Sciences Industry PartexAI, the technology and product development company focused on...
PartexAI signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India
PartexAI is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. PartexAI has executed an MoU to provide an academic license for its iP...
German VC firm invests in Data as a Service startup PartexAI
PartexAI, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture V...
Partex wins Horizon Interactive Gold Award for Curia App
Read More